Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

OncoGenex Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Jan 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - OncoGenex Pharmaceuticals Inc (OGXI-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

05 Feb 2016 Thomson Reuters Stock Report 12 $25.00

OGXI: Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

05 Feb 2016 New Constructs, LLC 10 $25.00

ValuEngine Rating and Forecast Report for OGXI

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

31 Jan 2016 ValuEngine, Inc. 11 $25.00

ONCOGENEX PHARMACEUTICALS INC (OGXI=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

30 Jan 2016 Pechala's Reports 2 $25.00

Value Graph: ONCOGENEX PHARM -- OGXI

29 Jan 2016 Ford Investor Services, Inc. 1 $12.00

Oncogenex Pharmaceuticals, Inc. (OGXI) - Financial Analysis Review

Oncogenex Pharmaceuticals, Inc. (OGXI) - Financial Analysis Review Summary Oncogenex Pharmaceuticals, Inc. (OncoGenex) is a b...

21 Jan 2016 GlobalData 47 $300.00

Wright Investors Service Comprehensive Report for Oncogenex Pharmaceuticals, Incorporation

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

10 Jan 2016 Wright Reports 56 $75.00

OncoGenex Pharmaceuticals

09 Jan 2016 S&P Capital IQ Quantitative Report 9 $104.00

Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ONCOGENEX PHARMACEUTICALS including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.

08 Jan 2016 Jefferson Research 11 $20.00